CGEN · Healthcare · $227M
$2.40+2.14%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Float 1.8% · biweekly · settled 26.05.15
Among 327 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 매출은 약 22억 원(약 220만 달러)으로 1년 전 같은 기간과 거의 같은 수준이에요.”
In the company's words · 2026 1분기 earnings call